Here are five insights:
1. If the FDA deems antibacterial soaps unsafe and/or ineffective, the companies will be forced to reformulate the products and remove claims from their labels.
2. The agency plans to review hand sanitizers and will consider its separation rules for food-process workers.
3. While antibacterial soaps have been used for years, a lack of data exists linking the soaps to human health outcomes.
4. Some research suggests antibacterial soaps are contributing to the creation of antibiotic-resistant super bugs.
5. The $30 billion cleaning-products industry anxiously awaits the FDA review, which will analyze 22 chemicals. The industry maintains the products are safe and more effective than regular soap.
More articles on quality & infection control:
4 things to know about the risk factors of aspirin
18 ASC patient safety tools
30 confirmed Zika virus cases in Puerto Rico, more expected in near future — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
